• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural Antibodies Mediate Protection Against Acinetobacter baumannii Respiratory Infections.天然抗体介导对鲍曼不动杆菌呼吸道感染的保护。
J Infect Dis. 2023 Aug 11;228(3):353-363. doi: 10.1093/infdis/jiad069.
2
Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.鼻内免疫可预防小鼠鲍曼不动杆菌相关性肺炎。
Vaccine. 2015 Jan 1;33(1):260-7. doi: 10.1016/j.vaccine.2014.02.083. Epub 2014 Mar 31.
3
Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.用噬菌体进行鼻内治疗可使小鼠从鲍曼不动杆菌介导的肺炎中获救。
Future Microbiol. 2016 May;11:631-41. doi: 10.2217/fmb.16.11. Epub 2016 Feb 29.
4
DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection.DNA 疫苗编码鲍曼不动杆菌 OmpA 和 Pal 可有效保护小鼠免受肺部感染。
Mol Biol Rep. 2019 Oct;46(5):5397-5408. doi: 10.1007/s11033-019-04994-2. Epub 2019 Jul 24.
5
Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.鲍曼不动杆菌多重耐药株致小鼠肺炎模型的建立:滴鼻接种、气管内滴注和经口灌胃三种感染方法的比较。
PLoS One. 2021 Dec 2;16(12):e0260627. doi: 10.1371/journal.pone.0260627. eCollection 2021.
6
Antibiotic-Resistant Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI and in Experimental Pneumonia in Mice.耐抗生素的 易受新型铁螯合抗感染药物 DIBI 的影响,并在小鼠实验性肺炎中。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00855-19. Print 2019 Sep.
7
Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.针对多重耐药鲍曼不动杆菌的免疫接种在肺炎和败血症模型中均能有效保护小鼠。
PLoS One. 2014 Jun 23;9(6):e100727. doi: 10.1371/journal.pone.0100727. eCollection 2014.
8
Lipocalin2 as a potential antibacterial drug against Acinetobacter baumannii infection.脂钙蛋白 2 作为一种潜在的抗鲍曼不动杆菌感染的抗菌药物。
J Microbiol. 2022 Apr;60(4):444-449. doi: 10.1007/s12275-022-2007-1. Epub 2022 Mar 28.
9
Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model.抗鲍曼不动杆菌单链可变片段在免疫抑制小鼠肺炎模型中具有治疗效果。
BMC Microbiol. 2024 Feb 10;24(1):55. doi: 10.1186/s12866-023-03080-9.
10
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.挽救四环素类抗生素治疗多重耐药鲍曼不动杆菌肺部感染。
mBio. 2022 Feb 22;13(1):e0351721. doi: 10.1128/mbio.03517-21. Epub 2022 Jan 11.

引用本文的文献

1
The immunology of B-1 cells: from development to aging.B-1细胞的免疫学:从发育到衰老
Immun Ageing. 2024 Aug 2;21(1):54. doi: 10.1186/s12979-024-00455-y.

本文引用的文献

1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
2
Two Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains.从致命性坏死性筋膜炎感染中分离得到的两个分离株与标准株相比表现出明显的基因组和表型特征。
Front Cell Infect Microbiol. 2021 Apr 12;11:635673. doi: 10.3389/fcimb.2021.635673. eCollection 2021.
3
Host Innate Immune Responses to Infection.宿主对感染的固有免疫反应。
Front Cell Infect Microbiol. 2020 Sep 14;10:486. doi: 10.3389/fcimb.2020.00486. eCollection 2020.
4
Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients.住院患者泛耐药鲍曼不动杆菌感染导致的超额死亡率。
J Hosp Infect. 2020 Nov;106(3):447-453. doi: 10.1016/j.jhin.2020.09.009. Epub 2020 Sep 11.
5
B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage.B-1a 细胞通过绕过 pre-BCR 选择阶段获得其独特的特征。
Nat Commun. 2019 Oct 18;10(1):4768. doi: 10.1038/s41467-019-12824-z.
6
Research and analysis of 74 bloodstream infection cases of Acinetobacter baumannii and drug resistance.鲍曼不动杆菌血流感染 74 例的研究与分析及耐药性
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1782-1786. doi: 10.26355/eurrev_201803_14597.
7
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.发现、研究和开发新抗生素:世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.
8
Complexity of Complement Resistance Factors Expressed by Needed for Survival in Human Serum.人类血清中生存所需的补体抗性因子表达的复杂性。
J Immunol. 2017 Oct 15;199(8):2803-2814. doi: 10.4049/jimmunol.1700877. Epub 2017 Aug 30.
9
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.住院患者中广泛耐药鲍曼不动杆菌引起的肺炎:遗传关系、危险因素和死亡率
BMC Infect Dis. 2017 May 30;17(1):371. doi: 10.1186/s12879-017-2471-0.
10
The Immune Response against , an Emerging Pathogen in Nosocomial Infections.针对医院感染中一种新兴病原体的免疫反应
Front Immunol. 2017 Apr 12;8:441. doi: 10.3389/fimmu.2017.00441. eCollection 2017.

天然抗体介导对鲍曼不动杆菌呼吸道感染的保护。

Natural Antibodies Mediate Protection Against Acinetobacter baumannii Respiratory Infections.

机构信息

Department of Microbiology, Miami University, Oxford, Ohio, USA.

出版信息

J Infect Dis. 2023 Aug 11;228(3):353-363. doi: 10.1093/infdis/jiad069.

DOI:10.1093/infdis/jiad069
PMID:36951192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10420402/
Abstract

BACKGROUND

Acinetobacter baumannii causes a wide range of dangerous infections due to the emergence of pandrug-resistant strains. Therefore, there is a need for alternative therapeutics to treat these infections, including those targeting the host immune responses. However, immune responses, especially the humoral response against this pathogen, are poorly understood.

METHODS

This study investigated the lymphocyte-mediated innate immune resistance to A. baumannii AB5075 pulmonary infection using B- and T-cell-deficient (Rag2-/-) mice, the protective effect of natural antibodies (NAbs), and the expression of complement-mediated responses using a mouse pneumonia model.

RESULTS

Our results showed that intranasally infected Rag2-/- mice are impaired in clearing bacteria from lung, liver, and spleen at 24 hours postinfection compared to wildtype mice. Animal pretreatment with normal mouse serum or purified antibodies from naive mice rescued Rag2-/- mice from infection. Analysis of C3 complement protein binding demonstrated that NAbs increased C3 protein deposition on A. baumannii cells, indicating the activation of the classical complement pathway by NAbs.

CONCLUSIONS

Overall, our study shows that NAbs mediate innate immune resistance against A. baumannii, a finding that may lead to the development of effective therapies against human infections caused by this antibiotic-resistant A. baumannii.

摘要

背景

由于泛耐药菌株的出现,鲍曼不动杆菌引起了广泛的危险感染。因此,需要替代疗法来治疗这些感染,包括针对宿主免疫反应的治疗方法。然而,免疫反应,特别是针对这种病原体的体液反应,还了解甚少。

方法

本研究使用 B 细胞和 T 细胞缺陷(Rag2-/-)小鼠,研究了淋巴细胞介导的对 AB5075 型鲍曼不动杆菌肺部感染的固有免疫抵抗作用,天然抗体(NAbs)的保护作用,以及使用小鼠肺炎模型对补体介导反应的表达。

结果

我们的结果表明,与野生型小鼠相比,在感染后 24 小时,经鼻腔感染的 Rag2-/-小鼠肺部、肝脏和脾脏的细菌清除能力受损。用正常小鼠血清或来自未感染小鼠的纯化抗体预处理动物,可使 Rag2-/-小鼠免受感染。对 C3 补体蛋白结合的分析表明,NAbs 增加了 A. baumannii 细胞上 C3 蛋白的沉积,表明 NAbs 激活了经典的补体途径。

结论

总的来说,我们的研究表明,NAbs 介导了对鲍曼不动杆菌的固有免疫抵抗,这一发现可能导致针对这种抗生素耐药的鲍曼不动杆菌引起的人类感染的有效治疗方法的发展。